The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic tumors of pancreatobiliary origin.
 
Hyun S Kim
No Relationships to Disclose
 
Juan C. Camacho
No Relationships to Disclose
 
Bassel F. El-Rayes
Consulting or Advisory Role - Genentech/Roche; Merrimack; Merrimack
Research Funding - AVEO (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Genentech (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)